Reminyl

Reminyl is the brand name for the drug galantamine hydrobromide. It is licensed for the treatment of mild to moderately severe Alzheimer's disease.

Reminyl is not claimed to be a cure for Alzheimer's disease. It treats only the symptoms and there is no evidence to show that it could halt or reverse the process of cell damage that causes Alzheimer's disease.

Who might benefit?Reminyl is intended only for people with Alzheimer's disease, and not for people with other kinds of dementia. It is licensed only for people who are in the mild to moderately severe stages of the illness.

It is important to realise that unfortunately Reminyl will not help everyone who tries it.

Effects -The effect of the drug will vary for different people. Some will not notice an effect at all. Others may find that their condition improves, or that they stay the same when they would have expected to get gradually less able because of the progression of Alzheimer's disease.

For most who take it there will not be a dramatic improvement, but the drug may help to stop symptoms getting worse. Janssen-Cilag and Shire, who manufacture the drug, did studies looking at the drug’s effect on memory and understanding, behaviour and people’s ability to carry out daily living activities.

The results of the studies are averages, so some people did better and some worse than the average. It is not possible to tell whether the drug will have an effect for any particular person.

On one measure of understanding and memory, people with Alzheimer's disease without treatment normally score 5-11 points worse after a year. After a year on the high dose of Reminyl, the average score of people taking Reminyl had stayed the same, and about a third had improved by 4 points. However, it must be remembered that 15% of people taking the placebo (dummy pill) also improved by the same amount. (This is a common effect in clinical trials when people take a placebo.)

For those who took Reminyl, behavioural symptoms such as anxiety, hallucinations and wandering on average did not get worse over the course of a five month study. For some people these symptoms improved, while for those not taking the drug they got significantly worse.

For activities of daily living, on average, people taking Reminyl also remained the same over a year, whereas those not taking the drug got worse at activities like bathing, managing money and preparing food.

Buy Reminyl prescriptions online at Med Store.

Buy Online at Med Store - Click Here!

Why are more and more people deciding to buy Reminyl online instead of having their prescriptions filled at a local pharmacy store? For many it is the discount prices that are available online, compared to the expensive practice of paying full cost at a pharmacy in their local area. Also, online pharmacy sites offer extra convenience allowing customers to select and purchase prescription drugs over the Internet, pay using safe and secure payment processing and receive their medications quickly and discreetly through the mail.

You may be surprised to learn that by law you do not actually have to visit a doctor to get a prescription from him or her. Therefore it is not surprising that many websites offer the convenience and cost saving option of virtual consultations with doctors that you do not actually meet. Whether this is the best option for you and your health is of course a personal matter, but there is little doubt that online pharmacy sites offer discount prices on many of the hot prescription drugs like Viagra and Propencia, as well as Reminyl and many other medications that hard pressed consumers find too expensive to purchase at a local pharmacy.

<< Previous  Next >>

Category: Prescription Drugs

Package size, quantity: 8mg 28 Tablets

Manufacturer, brand name: JANSSEN CILAG

Reminyl is the brand name for the drug galantamine hydrobromide. It is licensed for the treatment of mild to moderately severe Alzheimer's disease.

Reminyl is not claimed to be a cure for Alzheimer's disease. It treats only the symptoms and there is no evidence to show that it could halt or reverse the process of cell damage that causes Alzheimer's disease.

Who might benefit?Reminyl is intended only for people with Alzheimer's disease, and not for people with other kinds of dementia. It is licensed only for people who are in the mild to moderately severe stages of the illness.

It is important to realise that unfortunately Reminyl will not help everyone who tries it.

Effects -The effect of the drug will vary for different people. Some will not notice an effect at all. Others may find that their condition improves, or that they stay the same when they would have expected to get gradually less able because of the progression of Alzheimer's disease.

For most who take it there will not be a dramatic improvement, but the drug may help to stop symptoms getting worse. Janssen-Cilag and Shire, who manufacture the drug, did studies looking at the drug’s effect on memory and understanding, behaviour and people’s ability to carry out daily living activities.

The results of the studies are averages, so some people did better and some worse than the average. It is not possible to tell whether the drug will have an effect for any particular person.

On one measure of understanding and memory, people with Alzheimer's disease without treatment normally score 5-11 points worse after a year. After a year on the high dose of Reminyl, the average score of people taking Reminyl had stayed the same, and about a third had improved by 4 points. However, it must be remembered that 15% of people taking the placebo (dummy pill) also improved by the same amount. (This is a common effect in clinical trials when people take a placebo.)

For those who took Reminyl, behavioural symptoms such as anxiety, hallucinations and wandering on average did not get worse over the course of a five month study. For some people these symptoms improved, while for those not taking the drug they got significantly worse.

For activities of daily living, on average, people taking Reminyl also remained the same over a year, whereas those not taking the drug got worse at activities like bathing, managing money and preparing food. Reminyl ( Galantamine ) Reminyl

More Prescription Drugs to buy online.

I've made an order, but didn't get any confirmation, why is that? Med Store always confirm their customers about their order status changes via email, but some emails could be failed because of the customer’s anti-spam security. In such cases, you need to pass the authorization process via their website and see the status of your order in your private zone. If there is still a problem with confirmation, Med Store support is open for any of your questions. Why are more and more people deciding to Discreet Internet Pharmacy instead of having their prescriptions filled at a local pharmacy store? For many it is the discount prices that are available online, compared to the expensive practice of paying full cost at a pharmacy in their local area. Also, online pharmacy sites offer extra convenience allowing customers to select and purchase prescription drugs over the Internet, pay using safe and secure payment processing and receive their medications quickly and discreetly through the mail.

I have placed the order but the processor declined my payment, my credit card works perfect, what is the matter? All the money transactions are made directly through your bank system. If your credit card is not accepted you have to call your bank and ask the reason for this decline. You may be surprised to learn that by law you do not actually have to visit a doctor to get a prescription from him or her. Therefore it is not surprising that many websites offer the convenience and cost saving option of virtual consultations with doctors that you do not actually meet. Whether this is the best option for you and your health is of course a personal matter, but there is little doubt that online pharmacy sites offer discount prices on many of the hot prescription drugs like Viagra and Propencia, as well as many other medications that hard pressed consumers find too expensive to purchase at a local pharmacy.

Prescription Drugs News Update : Use of diabetes drugs rises 40 per cent in five years: official data. Prescriptions for drugs to treat diabetes have increased 40 per cent in five years as the obesity epidemic and improved diagnosis increases the number of people on the medicines. Last year there were 35.5m prescriptions written for drugs to treat diabetes, costing around Ј650m, official figures have shown. This is a rise of more than 40 per cent since 2004/5. Experts said this is due to both an increase in prevalence of diabetes as obesity – which is linked to the type 2 form of the disease – continues to rise. The number of people suffering from type 1 diabetes, which is not linked to weight or lifestyle, is also increasing yearly. GPs have been given incentives to identify people with diabetes and treat them, increasing the proportion of people with the condition who have been diagnosed and are receiving treatment. The development of new treatments has also contributed the increase in both volume of drugs prescribed and cost, experts said. Diabetes now accounts for almost one in 13 prescriptions written by GPs in England, compared with one in 20 five years ago. Tim Straughan, chief executive of the NHS Information Centre, said: “This report provides an insight into both national and local prescribing patterns for what is an increasingly prevalent condition in England. "It shows that both the total prescription items being dispensed to treat diabetes have increased markedly and the total net ingredient cost to the NHS of those items has increased by almost Ј200 million since 2004/5." Simon O’Neill, Director of Care, Information and Advocacy at Diabetes UK, said: “This large rise in cost of diabetes drug prescriptions and costs appears to be equally due to the far greater population of people with diabetes and to the wider prescribing of newer and more expensive therapies. “Diabetes UK believes that people with diabetes should have access to the most appropriate treatment to manage their condition. For those for whom older therapies are effective, they should be allowed continued access to those but where people with diabetes are unable to manage their diabetes effectively, a wider range of treatment options are required." : Doctors who are rude to colleagues could put patient safety at risk because the stressful atmosphere created distracts staff, a medical defence union has warned. Following a report in the British Medical Journal showing rudeness is a distraction, the Medical and Dental Defence Union of Scotland, is reminding doctors that their overriding duty is the care of their patients.